LGND - Ligand Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LGND is currently covered by 5 analysts with an average price target of $207.55. This is a potential upside of $17.58 (9.25%) from yesterday's end of day stock price of $189.97.

Ligand Pharmaceuticals's activity chart (see below) currently has 157 price targets and 108 ratings on display. The stock rating distribution of LGND is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 91.52% with an average time for these price targets to be met of 375.62 days.

Highest price target for LGND is $175, Lowest price target is $143, average price target is $156.25.

Most recent stock forecast was given by ROBERT WASSERMAN from BENCHMARK on 01-Sep-2025. First documented stock forecast 11-Feb-2014.

Currently out of the existing stock ratings of LGND, 12 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$175

$-11.98 (-6.41%)

$135

1 months 26 days ago
(01-Sep-2025)

10/10 (100%)

$11.27 (6.88%)

196

Buy

$160

$-26.98 (-14.43%)

$150

10 months 12 days ago
(15-Dec-2024)

15/15 (100%)

$37.66 (30.78%)

511

Buy

$157

10 months 17 days ago
(10-Dec-2024)

35/39 (89.74%)

$35.75 (29.48%)

620

Buy

$143

$-43.98 (-23.52%)

$140

10 months 17 days ago
(10-Dec-2024)

5/5 (100%)

$22.64 (18.81%)

305

Buy

$147

$-39.98 (-21.38%)

$135

11 months 20 days ago
(07-Nov-2024)

2/2 (100%)

$25.75 (21.24%)

280

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LGND (Ligand Pharmaceuticals) average time for price targets to be met?

On average it took 375.62 days on average for the stock forecasts to be realized with a an average price target met ratio 91.52

Which analyst has the current highest performing score on LGND (Ligand Pharmaceuticals) with a proven track record?

JOSEPH PANTGINIS

Which analyst has the most public recommendations on LGND (Ligand Pharmaceuticals)?

Joseph Pantginis has 28 price targets and 24 ratings on LGND

Which analyst is the currently most bullish on LGND (Ligand Pharmaceuticals)?

Jeff Johnson with highest potential upside - $4.82

Which analyst is the currently most reserved on LGND (Ligand Pharmaceuticals)?

Esther Rajavelu with lowest potential downside - -$121.48

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?